Abstract
Objective
To evaluate the nephrotoxic and opioid-sparing effects of ketorolac in children after cardiac surgery.
Design
A retrospective cohort study.
Setting
A Cardiac Critical Care Unit in a university-affiliated children’s hospital.
Subjects
Children less than 18 years of age who underwent low-risk cardiac surgery from July 2002 to December 2005.
Results
Among 248 children studied, 108 received ketorolac and 140 did not. The ketorolac group was older, included a larger proportion of atrial septum defect repairs and a smaller proportion of ventricular septum defect repairs compared to the control group. The median change in serum creatinine did not differ between the ketorolac group and the control group (% change [IQR]); 12% [1–25] increase versus 12% [−3 to 31] increase, P = 0.86. On postoperative day 0 or 1, the ketorolac group received less opioids than control group. There was no difference in duration of mechanical ventilation or in length of stay between groups.
Conclusion
Ketorolac started in the first 12 h after a low-risk cardiac surgery in children is not associated with a measurable difference in renal function. The data suggest that ketorolac may be effective in reducing the exposure to opioids. Further studies are required to define subsets of children after cardiac surgery who could safely benefit from ketorolac therapy to reduce pain.
Similar content being viewed by others
Abbreviations
- ASD:
-
Atrial septum defect
- CCCU:
-
Cardiac Critical Care Unit
- VSD:
-
Ventricular septum defect
- FLACC:
-
Faces, Legs, Activity, Cry, and Consolability
- IQR:
-
Interquartile range
- NSAID:
-
Nonsteroidal anti-inflammatory drug
- POD:
-
Postoperative day
- RACHS-1:
-
Risk adjustment for congenital heart surgery
- RV–PA:
-
Right ventricle to pulmonary artery
References
Lieh-Lai MW, Kauffman RE, Uy HG, Danjin M, Simpson PM (1999) A randomized comparison of ketorolac tromethamine and morphine for postoperative analgesia in critically ill children. Crit Care Med 27:2786–2791
Gunter JB, Varughese AM, Harrington JF, Wittkugel EP, Patankar SS, Matar MM, Lowe EE, Myer CM III, Willging JP (1995) Recovery and complications after tonsillectomy in children: a comparison of ketorolac and morphine. Anesth Analg 81:1136–1141
Keidan I, Zaslansky R, Eviatar E, Segal S, Sarfaty SM (2004) Intraoperative ketorolac is an effective substitute for fentanyl in children undergoing outpatient adenotonsillectomy. Paediatr Anaesth 14:318–323
Romsing J, Ostergaard D, Walther-Larsen S, Valentin N (1998) Analgesic efficacy and safety of preoperative versus postoperative ketorolac in paediatric tonsillectomy. Acta Anaesthesiol Scand 42:770–775
Rusy LM, Houck CS, Sullivan LJ, Ohlms LA, Jones DT, McGill TJ, Berde CB (1995) A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analg 80:226–229
Splinter WM, Rhine EJ, Roberts DW, Reid CW, MacNeill HB (1996) Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 43:560–563
Sutters KA, Levine JD, Dibble S, Savedra M, Miaskowski C (1995) Analgesic efficacy and safety of single-dose intramuscular ketorolac for postoperative pain management in children following tonsillectomy. Pain 61:145–153
Burd RS, Tobias JD (2002) Ketorolac for pain management after abdominal surgical procedures in infants. South Med J 95:331–333
Chauhan RD, Idom CB, Noe HN (2001) Safety of ketorolac in the pediatric population after ureteroneocystostomy. J Urol 166:1873–1875
Gonzalez A, Smith DP (1998) Minimizing hospital length of stay in children undergoing ureteroneocystostomy. Urology 52:501–504
Park JM, Houck CS, Sethna NF, Sullivan LJ, Atala A, Borer JG, Cilento BG, Diamond DA, Peters CA, Retik AB, Bauer SB (2000) Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation. Anesth Analg 91:11–15
Munro HM, Walton SR, Malviya S, Merkel S, Voepel-Lewis T, Loder RT, Farley FA (2002) Low-dose ketorolac improves analgesia and reduces morphine requirements following posterior spinal fusion in adolescents. Can J Anaesth 49:461–466
Vitale MG, Choe JC, Hwang MW, Bauer RM, Hyman JE, Lee FY, Roye DP Jr (2003) Use of ketorolac tromethamine in children undergoing scoliosis surgery. an analysis of complications. Spine J 3:55–62
Moffett BS, Wann TI, Carberry KE, Mott AR (2006) Safety of ketorolac in neonates and infants after cardiac surgery. Paediatr Anaesth 16:424–428
Gupta A, Daggett C, Ludwick J, Wells W, Lewis A (2005) Ketorolac after congenital heart surgery: does it increase the risk of significant bleeding complications? Paediatr Anaesth 15:139–142
Gupta A, Daggett C, Drant S, Rivero N, Lewis A (2004) Prospective randomized trial of ketorolac after congenital heart surgery. J Cardiothorac Vasc Anesth 18:454–457
Carney DE, Nicolette LA, Ratner MH, Minerd A, Baesl TJ (2001) Ketorolac reduces postoperative narcotic requirements. J Pediatr Surg 36:76–79
Cepeda MS, Carr DB, Miranda N, Diaz A, Silva C, Morales O (2005) Comparison of morphine, ketorolac, and their combination for postoperative pain: results from a large, randomized, double-blind trial. Anesthesiology 103:1225–1232
Fayaz MK, Abel RJ, Pugh SC, Hall JE, Djaiani G, Mecklenburgh JS (2004) Opioid-sparing effects of diclofenac and paracetamol lead to improved outcomes after cardiac surgery. J Cardiothorac Vasc Anesth 18:742–747
Brocks DR, Jamali F (1992) Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 23:415–427
Jones SF, Ulyatt D (1994) Ketorolac and renal impairment. Anaesth Intensive Care 22:113–114
Quan DJ, Kayser SR (1994) Ketorolac induced acute renal failure following a single dose. J Toxicol 32:305–309
Roy R, Griffiths K (2003) The 2003–2004 formulary of drugs. Drug Information Service, The Hospital for Sick Children, Canada
Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S (1997) The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 23:293–297
Romsing J, Moller-Sonnergaard J, Hertel S, Rasmussen M (1996) Postoperative pain in children: comparison between ratings of children and nurses. J Pain Symptom Manage 11:42–46
Kliegman RM, Behrman RE, Jenson HB, Stanton BF (2007) Nelson textbook of pediatrics. Saunders, Philadelphia
Yaster M, E.J. K, Kaplan RF, Cote CJ, Lappe DG (1997) Pediatric pain management and sedation handbook. Mosby, St. Louis
Littell RC, Stroup WW, Freund RJ (2002) SAS for linear models, 4th edn. SAS Publishing, Cary
Littell RC, Henry PR, Ammerman CB (1998) Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 76:1216–1231
Inoue M, Caldarone CA, Cox PN, Ito S, Frndova H, Taddio A, Guerguerian AM (2007) Efficacy of postoperative ketorolac in children undergoing cardiac surgery. In: Pediatric Academic Societies’ Annual meeting. Toronto, Canada
Inoue M, Ito S, Caldarone CA, Cox PN, Frndova H, Guerguerian AM, Tadido A (2006) Safety of ketorolac in children after cardiac surgery. Crit Care Med 34:A152 (abstract supplement)
Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123:110–118
van den Anker JN, Tibboel D, van Schaik RH (2007) Pharmacogenetics and pharmacogenomics of analgesic drugs. In: Anand KJS, Stevens BJ, McGrath PJ (eds) Pain in neonates and infants, 3rd edn. Elsevier, Philadelphia, pp 103–113
Wilkinson GR (2005) Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–2221
Kist-van Holthe tot Echten JE, Goedvolk CA, Doornaar MB, van der Vorst MM, Bosman-Vermeeren JM, Brand R, van der Heijden AJ, Schoof PH, Hazekamp MG (2001) Acute renal insufficiency and renal replacement therapy after pediatric cardiopulmonary bypass surgery. Pediatr Cardiol 22:321–326
Herrero-Morin JD, Malaga S, Fernandez N, Rey C, Dieguez MA, Solis G, Concha A, Medina A (2007) Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children. Crit Care 11:R59
Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231–1238
Acknowledgments
The authors would like to acknowledge Ms. Gail Williams for her help with the retrieval of data from Toronto Cardiovascular Surgery Database for Congenital Heart Surgery in Division of Cardiovascular Surgery, Hospital for Sick Children, and Karen Wong, BSc Pharm, from the Department of Pharmacy, Hospital for Sick Children, for the assistance in the literature search.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inoue, M., Caldarone, C.A., Frndova, H. et al. Safety and efficacy of ketorolac in children after cardiac surgery. Intensive Care Med 35, 1584–1592 (2009). https://doi.org/10.1007/s00134-009-1541-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-009-1541-1